The Finger iridectomy technique: small incision biopsy of anterior segment tumours
Aims: To develop a minimally invasive, maximally effective method to biopsy anterior segment tumours. Methods: A 25 gauge aspiration cutter (vitrector) was used to biopsy anterior segment tumours. The probe was introduced under sodium hyaluronate 1% and through a 1 mm incision. Aspiration (600 mm Hg...
Saved in:
Published in: | British journal of ophthalmology Vol. 89; no. 8; pp. 946 - 949 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
BMA House, Tavistock Square, London, WC1H 9JR
BMJ Publishing Group Ltd
01-08-2005
BMJ BMJ Publishing Group LTD Copyright 2005 British Journal of Ophthalmology |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aims: To develop a minimally invasive, maximally effective method to biopsy anterior segment tumours. Methods: A 25 gauge aspiration cutter (vitrector) was used to biopsy anterior segment tumours. The probe was introduced under sodium hyaluronate 1% and through a 1 mm incision. Aspiration (600 mm Hg) cutting (300 cpm) was performed to obtain specimens for cytology and histopathology. Results: Diagnostic material was obtained in nine of 10 (90%) cases. Diagnoses included iris naevus, iris stroma, malignant melanoma, melanocytoma, epithelial inclusion cyst, and sarcoid granuloma. All corneal wounds were self sealing. One patient developed a transient postoperative increase in intraocular pressure. Within the follow up of this study, no patients suffered intraocular haemorrhage, infection, cataract or vision loss. Conclusion: The Finger iridectomy technique was a minimally invasive and very effective biopsy technique. Aspiration cutting yielded relatively large pieces of tissue (and cells) used for cytopathological and histopathological evaluation. Small incision surgery allowed for rapid rehabilitation and no significant complications. |
---|---|
Bibliography: | href:bjophthalmol-89-946.pdf local:0890946 ark:/67375/NVC-9N9L699V-R istex:354E4615BB2CB912FBE405C0BA835B16C42B6B05 Correspondence to: Paul T Finger MD, FACS, The New York Eye Cancer Center,115 East 61st Street, New York City, NY 10021, USA; pfinger@eyecancer.com PMID:16024840 ObjectType-Case Study-3 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-2 The authors have no proprietary interest in the equipment used in this study. Correspondence to: Paul T Finger MD, FACS, The New York Eye Cancer Center,115 East 61st Street, New York City, NY 10021, USA; pfinger@eyecancer.com Supported by The EyeCare Foundation, Research to Prevent Blindness, and The New York Eye and Ear Infirmary Research Fund, New York City, New York, USA. |
ISSN: | 0007-1161 1468-2079 |
DOI: | 10.1136/bjo.2004.062653 |